GGrantIndex
Sort

8,912 grants matching sars cov 2

Anticytokine Autoantibodies in COVID-19

$48,284
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Immune response to COVID-19 vaccination in individuals with immune disorders

$48,284
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Molecular Mechanisms of SARS-CoV-2 Infection and Therapeutic Targets

$48,220
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings

$48,219
Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2025 · AI

Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19

$47,982
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED

$47,928
Robert Rodriguez · University Of California, San Francisco · R01 · FY2023 · AI

Building next generation sequencing capacity at Wisconsin Veterinary Diagnostic Laboratory for diagnosis of COVID-19 (SARS-CoV-2 infection) in animals

$47,800
Ailam Lee Lim · University Of Wisconsin-Madison · U18 · FY2022 · FD

Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study

$47,729
Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH

Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19

$47,717
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Immune-epithelial progenitor interactions drive age-associated dysplastic lung repair post viral pneumonia

$47,694
Harish Narasimhan · University Of Virginia · F31 · FY2023 · HL

Microbial Dysbiosis and Epithelial Dysfunction in Vitamin A-deficient Lungs

$47,694
Kiloni Quiles · Boston University Medical Campus · F31 · FY2023 · HL

The Respiratory Microbiome in COVID-19: Associations with Severity, Risk Factors, and Host Pathways

$47,694
Carter Merenstein · University Of Pennsylvania · F31 · FY2023 · HL

Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19

$47,482
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium

$47,470
Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI

Balancing epithelial cell resistance and resilience to respiratory viral infections

$46,967
Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2023 · HL

Defining the role of natural killer cells in COVID-19

$46,752
Madeline Jane Lee · Stanford University · F31 · FY2022 · AI

A new therapeutic approach against kidney damage in LN and COVID-19

$46,752
Veronica Villanueva · Rush University Medical Center · F31 · FY2022 · DK

Type 1-2 immune cross-regulation in the lung

$46,473
Sofia Caryotakis · University Of California, San Francisco · F31 · FY2025 · HL

Countermeasures against COVID-19

$46,470
Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Coronavirus Antagonism of the OAS-RNase L Pathway

$46,470
Joshua Mathew Thornbrough · University Of Pennsylvania · F32 · FY2015 · AI

Diversity Supplement to Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women

$46,410
Ten㉠T Lewis · Emory University · R01 · FY2023 · HL

Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques

$46,196
Kristina Abel · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI

Trafficking of Lymphocyte Subsets in Host Defense and Immunopathogenesis in COVID-19

$46,160
Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Exploring the Potential of Natural Products to Combat COVID-19

$46,036
Caitlin Jaime Risener · Emory University · F31 · FY2022 · AT

Suppression of Host Antiviral Responses by a SARS-CoV-2 Histone Mimetic

$46,036
Irene Po-Ru Chen · University Of California, San Francisco · F31 · FY2021 · AI